<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T02:59:45Z</responseDate>
  <request identifier="oai:figshare.com:article/34038477" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34038477</identifier>
        <datestamp>2026-10-01T04:33:52Z</datestamp>
        <setSpec>category_16</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_Clinical, functional, and quality-of-life characteristics of women with comorbid fibromyalgia and irritable bowel syndrome and their associations with FIQR scores.docx</dc:title>
          <dc:creator>Antonella Bianco (9541535)</dc:creator>
          <dc:creator>Nicola Verrelli (22516613)</dc:creator>
          <dc:creator>Giuseppe Riezzo (22516643)</dc:creator>
          <dc:creator>Gaetana Laselva (22516607)</dc:creator>
          <dc:creator>Marco Grasso (338528)</dc:creator>
          <dc:creator>Isabella Franco (9541532)</dc:creator>
          <dc:creator>Laura Prospero (22516604)</dc:creator>
          <dc:creator>Benedetta D’Attoma (22516610)</dc:creator>
          <dc:creator>Antonia Ignazzi (22516616)</dc:creator>
          <dc:creator>Maria Noemy Pastore (23589967)</dc:creator>
          <dc:creator>Elisa Grazioli (10305573)</dc:creator>
          <dc:creator>Attilio Parisi (22173577)</dc:creator>
          <dc:creator>Francesco Russo (125873)</dc:creator>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>comorbidity</dc:subject>
          <dc:subject>exercise prescription</dc:subject>
          <dc:subject>fibromyalgia</dc:subject>
          <dc:subject>functional assessment</dc:subject>
          <dc:subject>irritable bowel syndrome</dc:subject>
          <dc:subject>quality of life</dc:subject>
          <dc:description>Background&lt;p&gt;Fibromyalgia (FM) and irritable bowel syndrome (IBS) frequently co-occur, sharing pathophysiological mechanisms such as central sensitization and gut-brain axis dysregulation. Given that exercise is a first-line non-pharmacological intervention for FM, detailed baseline characterization may inform future exercise-based research. This study aimed to describe the physical, functional, symptomatic, and quality-of-life profile of women with FM+IBS comorbidity in relation to FM severity, assessed continuously and, secondarily, categorically using the Revised Fibromyalgia Impact Questionnaire (FIQR).&lt;/p&gt;Methods&lt;p&gt;This cross-sectional observational study, conducted at IRCCS “Saverio de Bellis” (Castellana Grotte, Bari, Italy), enrolled 33 women (mean age 47.7 ± 8.6 years) diagnosed with FM (2016 ACR criteria) and IBS (Rome IV criteria). Participants were stratified into three groups by FIQR score: Remission/Mild (n=7), Moderate (n=13), and High Severity (n=13). FIQR total score was analyzed as a continuous exposure using Spearman correlations with bootstrapped 95% CIs as the primary analysis; the three-group stratification was retained as a secondary, exploratory presentation. Assessments included pain (VAS), tender points, gastrointestinal symptoms (IBS-SSS), kinesiophobia (TSK), sleep quality (PSQI), physical activity (IPAQ), functional fitness tests, and quality of life (SF-36).&lt;/p&gt;Results&lt;p&gt;Perceived pain showed the strongest association with FIQR severity (Spearman’s rho=0.57, p&lt;0.001), with values nearly doubling in the High Severity versus Remission/Mild stratum. Physical activity level (IPAQ; exact p=0.021) differed significantly across FIQR strata, with greater inactivity in the Moderate group. Lower-limb functional strength/endurance, handgrip strength, six-minute walk distance, kinesiophobia, and SF-36 Mental Component Summary were all significantly associated with continuous FIQR (all p&lt;0.05); the Sit-to-Stand difference across categorical strata, significant under standard ANOVA (p=0.048), lost significance under Welch’s ANOVA (p=0.148) and Kruskal-Wallis testing (p=0.072). Gastrointestinal burden remained elevated across all groups, with no clear association with FIQR severity (rho=0.29, p=0.097). Sleep quality and SF-36 scores were markedly impaired regardless of FIQR class.&lt;/p&gt;Conclusions&lt;p&gt;In this exploratory sample, greater FM severity was primarily associated with increased pain and reduced lower-limb functional capacity, while gastrointestinal burden remained consistently elevated across the severity spectrum. These descriptive, hypothesis-generating findings may help guide the design of future, adequately powered studies addressing pain threshold, functional capacity, and gastrointestinal tolerance in exercise management of FM+IBS.&lt;/p&gt;</dc:description>
          <dc:date>2026-10-01T04:33:52Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/fphys.2026.1922718.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_Clinical_functional_and_quality-of-life_characteristics_of_women_with_comorbid_fibromyalgia_and_irritable_bowel_syndrome_and_their_associations_with_FIQR_scores_docx/34038477</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
